DMMR CANCER
Clinical trials for DMMR CANCER explained in plain language.
Never miss a new study
Get alerted when new DMMR CANCER trials appear
Sign up with your email to follow new studies for DMMR CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to spare surgery for certain cancer patients
Disease control Recruiting nowThis phase 2 trial is testing whether a combination of immunotherapy drugs (sintilimab, IBI310, and lenvatinib) can help people with non-metastatic dMMR/MSI-H stomach or colon cancers avoid radical surgery. About 34 participants will receive up to 24 weeks of treatment, and those…
Matched conditions: DMMR CANCER
Phase: PHASE2 • Sponsor: Peking University • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
New pill shows promise for Hard-to-Treat cancers
Disease control Recruiting nowThis early-stage study tests a new oral drug, MOMA-341, alone or with other treatments, in people with advanced solid tumors that have specific genetic changes (MSI-H or dMMR). The main goal is to check safety and find the best dose. About 132 adults whose cancer has not responde…
Matched conditions: DMMR CANCER
Phase: PHASE1 • Sponsor: MOMA Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:08 UTC